Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Altor on acquisition of Palette Software
Mandate

Vinge advises Altor on acquisition of Palette Software

July 02, 2021 Employment and Benefits M&A IT, Telecommunications and Outsourcing

Vinge is advising Altor Fund V (“Altor”) in its acquisition of a majority stake in Palette Software AB (“Palette”). Altor acquires the company from previous owner Monterro, founders and management. The ambition is to accelerate investments in growing Palette into one of the leading accounts payable automation software providers globally.

Palette is an Accounts Payable automation (AP Automation) software company offering procure-to-pay and digital invoice processing solutions for the SME and mid-market segments. The company, which has 120 employees and is headquartered in Stockholm, has more than 1,500 customers predominantly in Sweden and Finland. Palette has annual recurring revenue (ARR) of approximately 200 MSEK.

The Vinge team advising Altor includes partner Christina Kokko and associates Carl Sander, Vilhelm Rondahl, Elsie Nassar and Nando Basic (M&A), Mathilda Persson and Lisa Hörnqvist (IT), Carl Östlund (Employment), and VDR-specialist Sara Dahlros Sköld.

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

 Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

 Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025